63 related articles for article (PubMed ID: 1669716)
1. Amyloid diseases: abnormal protein aggregation in neurodegeneration.
Koo EH; Lansbury PT; Kelly JW
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):9989-90. PubMed ID: 10468546
[No Abstract] [Full Text] [Related]
2. Changes in the amyloid editorial board members and in editor positions.
Schönland S; Westermark P
Amyloid; 2024 Jun; 31(2):85. PubMed ID: 38781088
[No Abstract] [Full Text] [Related]
3. Apolipoprotein J and Alzheimer's amyloid beta solubility.
Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs.
Wisniewski T; Lalowski M; Bobik M; Russell M; Strosznajder J; Frangione B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):575-80. PubMed ID: 8573095
[TBL] [Abstract][Full Text] [Related]
5. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.
Ghetti B; Piccardo P; Spillantini MG; Ichimiya Y; Porro M; Perini F; Kitamoto T; Tateishi J; Seiler C; Frangione B; Bugiani O; Giaccone G; Prelli F; Goedert M; Dlouhy SR; Tagliavini F
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):744-8. PubMed ID: 8570627
[TBL] [Abstract][Full Text] [Related]
6. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
Ghiso J; Matsubara E; Koudinov A; Choi-Miura NH; Tomita M; Wisniewski T; Frangione B
Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):27-30. PubMed ID: 8328966
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of Alzheimer's amyloid--Dutch variant.
Wisniewski T; Frangione B
Mol Neurobiol; 1992; 6(1):75-86. PubMed ID: 1463589
[TBL] [Abstract][Full Text] [Related]
8. Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.
Zanusso GL; Moretto G; Bonetti B; Monaco S; Rizzuto N
Ital J Neurol Sci; 1992 Sep; 13(6):493-9. PubMed ID: 1385357
[TBL] [Abstract][Full Text] [Related]
9. A beta amyloidogenesis: unique, or variation on a systemic theme?
Kisilevsky R; Fraser PE
Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis.
Castaño EM; Frangione B
Brain Pathol; 1991 Jul; 1(4):263-71. PubMed ID: 1669716
[No Abstract] [Full Text] [Related]
11. Unifying features of systemic and cerebral amyloidosis.
Ghiso J; Wisniewski T; Frangione B
Mol Neurobiol; 1994 Feb; 8(1):49-64. PubMed ID: 7916192
[TBL] [Abstract][Full Text] [Related]
12. The role of beta-amyloid in Alzheimer's disease.
Sinha S
Med Clin North Am; 2002 May; 86(3):629-39. PubMed ID: 12168562
[TBL] [Abstract][Full Text] [Related]
13. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement.
Sandgren O
Surv Ophthalmol; 1995; 40(3):173-96. PubMed ID: 8599154
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid precursor protein and early-onset Alzheimer's disease.
Hendriks L; Jonghe CDXs ; Cras P; Martin JJ; Broeckhoven CV
Ciba Found Symp; 1996; 199():170-80. PubMed ID: 8915610
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
